| 发明名称 |
LIPOCALIN 2 AS A BIOMARKER FOR IL-17 INHIBITOR THERAPY EFFICACY |
| 摘要 |
The present invention provides the use of lipocalin 2 (LCN2) as a biomarker for IL-17 mediated diseases and for monitoring the response of a patient to anti-IL-17 therapy. |
| 申请公布号 |
US2014080134(A1) |
申请公布日期 |
2014.03.20 |
| 申请号 |
US201314084047 |
申请日期 |
2013.11.19 |
| 申请人 |
UCB PHARMA S.A. |
发明人 |
PLATT ADAM SAMUEL;RAPECKI STEPHEN EDWARD;FORTUNATO MARA;RAINEY DAVID ROBERT;RUNDLE JON LEIGH;SMITH PAUL ALFRED;WATT GILLIAN SAIRFULL |
| 分类号 |
C12Q1/68;G01N33/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
